344 related articles for article (PubMed ID: 32549355)
61. The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis.
Alhomrani M; Correia J; Zavou M; Leaw B; Kuk N; Xu R; Saad MI; Hodge A; Greening DW; Lim R; Sievert W
Front Pharmacol; 2017; 8():748. PubMed ID: 29114223
[No Abstract] [Full Text] [Related]
62. The Role of Extracellular Vesicles as Paracrine Effectors in Stem Cell-Based Therapies.
Bruno S; Kholia S; Deregibus MC; Camussi G
Adv Exp Med Biol; 2019; 1201():175-193. PubMed ID: 31898787
[TBL] [Abstract][Full Text] [Related]
63. Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury.
Zhang ZY; Hou YP; Zou XY; Xing XY; Ju GQ; Zhong L; Sun J
Kidney Blood Press Res; 2020; 45(1):95-108. PubMed ID: 31927554
[TBL] [Abstract][Full Text] [Related]
64. Association of Extracellular Membrane Vesicles with Cutaneous Wound Healing.
Than UTT; Guanzon D; Leavesley D; Parker T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468315
[TBL] [Abstract][Full Text] [Related]
65. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents.
Börger V; Bremer M; Ferrer-Tur R; Gockeln L; Stambouli O; Becic A; Giebel B
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28684664
[TBL] [Abstract][Full Text] [Related]
66. hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice.
Dong L; Pu Y; Chen X; Qi X; Zhang L; Xu L; Li W; Ma Y; Zhou S; Zhu J; Li Y; Wang X; Su C
Stem Cell Res Ther; 2020 Jan; 11(1):21. PubMed ID: 31918749
[TBL] [Abstract][Full Text] [Related]
67. Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.
Herrera Sanchez MB; Previdi S; Bruno S; Fonsato V; Deregibus MC; Kholia S; Petrillo S; Tolosano E; Critelli R; Spada M; Romagnoli R; Salizzoni M; Tetta C; Camussi G
Stem Cell Res Ther; 2017 Jul; 8(1):176. PubMed ID: 28750687
[TBL] [Abstract][Full Text] [Related]
68. The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.
Park S; In Hwang S; Kim J; Hwang S; Kang S; Yang S; Kim J; Kang W; Kim KH; Han DW; Paik YH
Stem Cell Res Ther; 2019 Jan; 10(1):21. PubMed ID: 30635054
[TBL] [Abstract][Full Text] [Related]
69. Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
Zhang B; Yeo RW; Tan KH; Lim SK
Int J Mol Sci; 2016 Feb; 17(2):174. PubMed ID: 26861305
[TBL] [Abstract][Full Text] [Related]
70. Subpopulations of extracellular vesicles and their therapeutic potential.
Lässer C; Jang SC; Lötvall J
Mol Aspects Med; 2018 Apr; 60():1-14. PubMed ID: 29432782
[TBL] [Abstract][Full Text] [Related]
71. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
[TBL] [Abstract][Full Text] [Related]
72. Extracellular Vesicles in Cardiovascular Theranostics.
Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
[TBL] [Abstract][Full Text] [Related]
73. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.
Guha D; Lorenz DR; Misra V; Chettimada S; Morgello S; Gabuzda D
J Neuroinflammation; 2019 Dec; 16(1):254. PubMed ID: 31805958
[TBL] [Abstract][Full Text] [Related]
74. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.
Dabrowska S; Andrzejewska A; Strzemecki D; Muraca M; Janowski M; Lukomska B
J Neuroinflammation; 2019 Nov; 16(1):216. PubMed ID: 31722731
[TBL] [Abstract][Full Text] [Related]
75. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
76. Biological Nanotherapeutics for Liver Disease.
Driscoll J; Wehrkamp C; Ota Y; Thomas JN; Yan IK; Patel T
Hepatology; 2021 Nov; 74(5):2863-2875. PubMed ID: 33825210
[TBL] [Abstract][Full Text] [Related]
77. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
78. Extracellular vesicles: A new therapeutic strategy for joint conditions.
Tofiño-Vian M; Guillén MI; Alcaraz MJ
Biochem Pharmacol; 2018 Jul; 153():134-146. PubMed ID: 29427625
[TBL] [Abstract][Full Text] [Related]
79. Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases.
Meldolesi J
Clin Exp Immunol; 2019 Jun; 196(3):318-327. PubMed ID: 30756386
[TBL] [Abstract][Full Text] [Related]
80. PAHs increase the production of extracellular vesicles both in vitro in endothelial cells and in vivo in urines from rats.
Le Goff M; Lagadic-Gossmann D; Latour R; Podechard N; Grova N; Gauffre F; Chevance S; Burel A; Appenzeller BMR; Ulmann L; Sergent O; Le Ferrec E
Environ Pollut; 2019 Dec; 255(Pt 1):113171. PubMed ID: 31539851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
